Toy Company KiwiCo Sees Children as 'Young Innovators'
*By: Madison Alworth*
Many toy makers may feel imperiled by the closing of Toys 'R' Us, but KiwiCo seems to be doing just fine.
The company, which sells kits that encourage kids to build and create their own toys, says sales have grown at an annual rate of about 60 percent a year since its founding in 2011.
"This year we are approaching $100 million in sales," said Sandra Oh Lin, the company's founder and CEO, in an interview with Cheddar.
KiwiCo took in a round of financing to the tune of $10 million early on. It started producing STEM-based toys, but evolved to sell crates of materials to build toys for everything from engineering to art to more.
"In a few weeks we are actually launching a new line called Atlas Crate, which is all about geography and encouraging kids to see themselves as global citizens," Oh Lin said.
"We are really about encouraging kids to see themselves as young innovators. We want them to embrace the thought that they are makers, that they have innate creativity. What we are trying to do is instill that creative confidence as well as the tools."
The crates are available as stand-alone products and through a subscription service. A [monthly subscription](https://www.kiwico.com/) starts at $19.95 but goes down in price if customers sign on for longer periods.
For the full segment, [click here.](https://cheddar.com/videos/kiwico-subscription-services-for-stem-toys)
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
